The vascular idea in glaucoma is apparently a scientific rationale for the appliance of HBOT. During this feeling, some experiments claimed an advancement while in the visual field without major improvements in intraocular pressure, in patients with glaucoma. OPDIVO® (nivolumab) is usually a